Sector pending / Surgical and Medical Instruments and ApparatusUpdated 2026-05-10 22:07 UTC

FRA/GM0N stock hub

FRA/GM0N has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/GM0Nis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/GM0N

In the news

Latest news · FRA/GM0N

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E15.9

P25 n/aP50 n/aP75 n/a

Trailing P/E17.7

P25 n/aP50 n/aP75 n/a

ROE13.3

P25 n/aP50 n/aP75 n/a

ROIC14.2

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/GM0N market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

208

Groups with data

Currency

USD

Showing 208 of 208 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	6,000
Employees Change	300%
Employees Change Percent	6
Enterprise value	EUR 8.4B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Surgical and Medical Instruments and Apparatus
Last refreshed	2026-05-10
Market cap	EUR 9B
Price	EUR 75.46
Price currency	EUR
Rev Per Employee	448,200.98x
Sic	3841
Symbol	fra/GM0N
Website	https://www.globusmedical.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.66%
EV Earnings	16.51x
EV/EBIT	14.89x
EV/EBITDA	10.21x
EV/FCF	15.88x
EV/Sales	3.19x
FCF yield	5.89%
Forward P/E	15.93x
P/B ratio	2.19x
P/E ratio	17.66x
P/S ratio	3.34x
PE Ratio10 Y	46.3x
PE Ratio3 Y	68.42x
PE Ratio5 Y	57.44x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	21.42%
EBITDA Margin	30.48%
FCF margin	19.68%
Gross margin	68.49%
Gross Profit	EUR 1.8B
Gross Profit Growth	26.17%
Gross Profit Growth Q	30.54%
Gross Profit Growth3 Y	38.83%
Gross Profit Growth5 Y	28.67%
Net Income	EUR 508.9M
Net Income Growth	216.18%
Net Income Growth Q	64.72%
Net Income Growth3 Y	42.86%
Net Income Growth5 Y	36.98%
Pretax Margin	21.24%
Profit Margin	18.92%
Profit Per Employee	EUR 84,809
ROA	8.18
Roa5y	6.25
ROCE	13.4
ROE	13.3
Roe5y	7.76
ROIC	14.17
Roic5y	11.55

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	14.15%
Cagr1y	20.75%
Cagr3y	13.95%
Cagr5y	4.61%
EPS Growth	221.1
EPS Growth Q	66.67
EPS Growth3 Y	29.79
EPS Growth5 Y	28.96
FCF Growth	16.79%
FCF Growth Q	15.26%
FCF Growth3 Y	73.42%
FCF Growth5 Y	29.89%
OCF Growth	20.6%
OCF Growth Q	14.14%
OCF Growth10 Y	18.48%
OCF Growth3 Y	60.84%
OCF Growth5 Y	28.75%
Revenue Growth	23.49x
Revenue Growth Q	27.04x
Revenue Growth3 Y	42.61x
Revenue Growth5 Y	30.29x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.61
Assets	EUR 4.7B
Cash	EUR 546.3M
Current Assets	EUR 1.9B
Current Liabilities	EUR 409.1M
Debt	EUR 99.9M
Debt EBITDA	EUR 0.12
Debt Equity	EUR 0.02
Debt FCF	EUR 0.19
Equity	EUR 4.1B
Liabilities	EUR 613.4M
Long Term Assets	EUR 2.9B
Long Term Liabilities	EUR 204.3M
Net Cash	EUR 593.3M
Net Cash By Market Cap	EUR 6.6
Net Cash Growth	85.65%
Net Debt EBITDA	EUR -0.72
Net Debt Equity	EUR -0.14
Net Debt FCF	EUR -1.12
Tangible Book Value	EUR 2.2B
Tangible Book Value Per Share	EUR 16.45

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.56
Inventory Turnover	1.36
Net Working Capital	EUR 954.8M
Quick ratio	2.83
Working Capital	EUR 1.5B
Working Capital Turnover	EUR 1.77

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.66%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	275.39%
1Y total return	20.74%
200-day SMA	65.97
3Y total return	47.96%
50-day SMA	76.77
50-day SMA vs 200-day SMA	50over200
5Y total return	25.25%
All Time High	90.5
All Time High Change	-16.62%
All Time High Date	2025-01-29
All Time Low	7.75
All Time Low Change	873.68%
All Time Low Date	2013-01-02
ATR	1.35
Ch YTD	1.29
High	75.46
High52	83.5
High52 Date	2026-01-09
High52ch	-9.63%
Low	75.46
Low52	44.4
Low52 Date	2025-07-22
Low52ch	69.96%
Ma50ch	-1.7%
Price vs 200-day SMA	14.38%
RSI	45.32
RSI Monthly	57.25
RSI Weekly	53.96
Sharpe ratio	1.02x
Sortino ratio	2.37
Total Return	1.66%
Tr YTD	1.29
Tr1m	-0.26%
Tr1w	-2.05%
Tr3m	2.67%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 576M
Operating Income Growth	47.26
Operating Income Growth Q	64.84
Operating Income Growth3 Y	39.38
Operating Income Growth5 Y	36.3
Operating margin	21.42

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	111,637,862%
Shares Insiders	17.52%
Shares Institutions	84.28%
Shares Qo Q	1.18%
Shares Yo Y	-1.66%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 486.7M
Average Volume	8.65x
Bv Per Share	30.25
CAPEX	EUR -145.9M
Ch10y	275.4
Ch1m	-0.26
Ch1w	-2.05
Ch1y	20.74
Ch3m	2.67
Ch3y	47.96
Ch5y	25.25
Ch6m	7.8
Change	0.59%
Change From Open	0
Close	75.02
Days Gap	0.59
Depreciation Amortization	238,315,480.3
Earnings Date	2026-05-07
EBIT	EUR 576M
EBITDA	EUR 819.8M
EPS	EUR 3.72
F Score	7
FCF	EUR 529.3M
FCF EV Yield	6.3x
Financing CF	-22,174,259
Fiscal Year End	December
Founded	2,003
Goodwill	1,219,990,912.1
Graham Number	57.57381
Graham Upside	-23.7
Income Tax	EUR 62.2M
Investing CF	-580,287,013
Is Primary Listing	0
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Lynch Fair Value	EUR 107
Lynch Upside	41.59
Ma150	71.57
Ma150ch	5.44%
Ma20	78.01
Ma20ch	-3.27%
Net CF	86,455,933
Open	75.46
P FCF Ratio	16.97
P OCF Ratio	13.31
Ppne	524,588,299.5
Price Date	2026-05-08
Price EBITDA	EUR 10.96
Ptbv Ratio	4.03
Relative Volume	6.13x
Revenue	2,689,205,887x
SBC By Revenue	1.59x
Share Based Comp	42,662,487
Tax By Revenue	2.31x
Tax Rate	10.9%
Tr6m	7.8%
Volume	0

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/GM0N pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/GM0N stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/GM0N?

Insider, institutional, and short-interest positioning.

Institutional ownership

+84.3%

Share of float held by funds and institutions

Insider ownership

+17.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-1.7%

Negative means the company is buying back shares.

Technical

FRA/GM0N momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

45.3

Neutral momentum band

Price vs 200-day MA

+14.4%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.02

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/GM0N

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/GM0N stock rating?

fra/GM0N is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/GM0N analysis?

The full report lives at /stocks/fra/GM0N/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/GM0N?

The latest report frames fra/GM0N around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/GM0N page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.